Prostatic neoplasms, castration-resistant Clinical Trials

Delta Trials indexes 37 clinical trials for Prostatic neoplasms, castration-resistant in its publicly accessible dataset. Of these, 9 enrolling participants at this time and 17 trials have reached completion. This research takes place spanning 349 research sites around the world. An additional 11 trials are in preparatory or other active non-recruiting stages. Since 2020, 3 trials were terminated, illustrating the dynamic nature of clinical research. Delta Trials updates this record as new data becomes available from ClinicalTrials.gov, providing a versioned view of how research activity has changed over time.